View Financial HealthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsNeighbourly Pharmacy 配当と自社株買い配当金 基準チェック /06Neighbourly Pharmacy現在配当金を支払っていません。主要情報0%配当利回り-0.5%バイバック利回り総株主利回り-0.5%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 14Neighbourly Pharmacy Inc. Announces CFO ChangesNeighbourly Pharmacy Inc. announced the appointment of J.P. Arcand as Chief Financial Officer. Mr. Arcand is a seasoned retail finance executive with over 20 years of experience. Mr. Arcand joins Neighbourly from Helly Hansen, a leading designer and retailer of sports apparel owned by Canadian Tire Corporation, where he most recently served as CFO in Norway, overseeing its global operations across 40 countries and multiple channels. At Neighbourly, Mr. Arcand will oversee all aspects of Neighbourly's financial operations, including financial planning and analysis, accounting, and treasury functions. He will work closely with the rest of the executive team to support Neighbourly's long-term growth objectives. Mr. Arcand succeeds Billy Wong who is leaving Neighbourly for another opportunity. Mr. Arcand will be starting at Neighbourly effective August 19, 2024.お知らせ • Mar 23Neighbourly Pharmacy Inc. COM to Be Deleted from OTC EquityNeighbourly Pharmacy Inc. COM (Canada) will be deleted from OTC Equity effective March 22, 2024, due to Acquisition /Merger /Amalgamation.お知らせ • Mar 21+ 1 more updateNeighbourly Closes Go-Private Deal with PersistenceNeighbourly Pharmacy Inc. has closed the previously announced plan of arrangement to be taken private by Persistence Capital Partners (PCP). "Today's announcement marks an important milestone for Neighbourly. We are excited for a bright future as a private company," said Skip Bourdo, chief executive officer of Neighbourly. "This going-private transaction provides us with increased flexibility to pursue our growth initiatives, invest in innovation and drive operational excellence. We are focused on continuing to grow our network of pharmacies and serve more communities across Canada." As a result of the transaction, the common shares are expected to be delisted from the Toronto Stock Exchange (TSX) at the close of trading on or about March 21, 2024. The company has submitted an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the company's public reporting requirements.お知らせ • Jan 23Neighbourly Pharmacy Inc. Announces Executive ChangesNeighbourly Pharmacy Inc. announced the appointment of Maura Dyer as Senior Vice President, People and Culture. Ms. Dyer is a seasoned human resources executive with over 20 years of experience at well-respected Canadian healthcare, telecommunications, and financial services organizations. Her expertise in talent acquisition, employee development, and HR operations will be instrumental in enhancing Neighbourly's reputation as a workplace that attracts and retains top talent. Most recently, Ms. Dyer led several Human Resources functions at Extendicare Inc., a leading provider of care and services for seniors across Canada. At Neighbourly, Ms. Dyer will lead the People and Culture team and will play a critical role in advancing the Company's growth through the development and continuous improvement of a Talent and Culture strategy. Ms. Dyer succeeds Roy Wieschkowski, who has decided to retire from corporate life after five successful years leading the Human Resources and Payroll teams at Neighbourly, supporting the Company's rapid growth and culture evolution. Mr. Wieschkowski's retirement marks the end of an accomplished 38 year-long career, leading Human Resources functions across various industry sectors including pharmaceuticals, retail, chemical and manufacturing. Ms. Dyer joins the Neighbourly team effective February 12, 2024.お知らせ • Jan 19Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024Neighbourly Pharmacy Inc. announced that they will report Q3, 2024 results at 7:00 AM, US Eastern Standard Time on Feb 13, 2024お知らせ • Oct 05PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million on October 3, 2023. As per consideration, the Persistence Capital Partners will pay CAD 20.50 in cash for each share of Neighbourly Pharmacy. The PCP GP secured fully committed debt and equity financing. Devon Park Advisors provided capital raising services to PCP. PCP currently beneficially owns or has control or direction over, directly or indirectly, 22.4 million common shares. The transaction has been unanimously approved by the Neighbourly Pharmacy board of directors. The transaction is subject to a definitive agreement, regulatory, court and/or stock exchange approvals, receiving an updated Fairness Opinion from TD and approval from shareholders of Neighbourly Pharmacy. The transaction is expected to close in the last calendar quarter of 2023 or early in the first calendar quarter of 2024. TD Securities acted as financial and provided fairness opinion to Neighbourly Pharmacy. Scotiabank and RBC Capital Markets acted as financial advisors to PCP. Stikeman Elliott LLP acted as legal advisor to PCP on the transaction. McCarthy Tétrault LLP acted as independent legal advisor to the Transaction Committee.決済の安定と成長配当データの取得安定した配当: NBLY.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: NBLY.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Neighbourly Pharmacy 配当利回り対市場NBLY.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (NBLY.F)0%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Consumer Retailing)1.0%アナリスト予想 (NBLY.F) (最長3年)0%注目すべき配当: NBLY.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: NBLY.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: NBLY.F US市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: NBLY.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/03/20 15:36終値2024/03/20 00:00収益2023/12/30年間収益2023/03/25データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neighbourly Pharmacy Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Kyle McPheeATB Cormark Historical (Cormark Securities)Clarence PowellBMO Capital Markets Equity ResearchChristopher LiDesjardins Securities Inc.4 その他のアナリストを表示
お知らせ • Aug 14Neighbourly Pharmacy Inc. Announces CFO ChangesNeighbourly Pharmacy Inc. announced the appointment of J.P. Arcand as Chief Financial Officer. Mr. Arcand is a seasoned retail finance executive with over 20 years of experience. Mr. Arcand joins Neighbourly from Helly Hansen, a leading designer and retailer of sports apparel owned by Canadian Tire Corporation, where he most recently served as CFO in Norway, overseeing its global operations across 40 countries and multiple channels. At Neighbourly, Mr. Arcand will oversee all aspects of Neighbourly's financial operations, including financial planning and analysis, accounting, and treasury functions. He will work closely with the rest of the executive team to support Neighbourly's long-term growth objectives. Mr. Arcand succeeds Billy Wong who is leaving Neighbourly for another opportunity. Mr. Arcand will be starting at Neighbourly effective August 19, 2024.
お知らせ • Mar 23Neighbourly Pharmacy Inc. COM to Be Deleted from OTC EquityNeighbourly Pharmacy Inc. COM (Canada) will be deleted from OTC Equity effective March 22, 2024, due to Acquisition /Merger /Amalgamation.
お知らせ • Mar 21+ 1 more updateNeighbourly Closes Go-Private Deal with PersistenceNeighbourly Pharmacy Inc. has closed the previously announced plan of arrangement to be taken private by Persistence Capital Partners (PCP). "Today's announcement marks an important milestone for Neighbourly. We are excited for a bright future as a private company," said Skip Bourdo, chief executive officer of Neighbourly. "This going-private transaction provides us with increased flexibility to pursue our growth initiatives, invest in innovation and drive operational excellence. We are focused on continuing to grow our network of pharmacies and serve more communities across Canada." As a result of the transaction, the common shares are expected to be delisted from the Toronto Stock Exchange (TSX) at the close of trading on or about March 21, 2024. The company has submitted an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the company's public reporting requirements.
お知らせ • Jan 23Neighbourly Pharmacy Inc. Announces Executive ChangesNeighbourly Pharmacy Inc. announced the appointment of Maura Dyer as Senior Vice President, People and Culture. Ms. Dyer is a seasoned human resources executive with over 20 years of experience at well-respected Canadian healthcare, telecommunications, and financial services organizations. Her expertise in talent acquisition, employee development, and HR operations will be instrumental in enhancing Neighbourly's reputation as a workplace that attracts and retains top talent. Most recently, Ms. Dyer led several Human Resources functions at Extendicare Inc., a leading provider of care and services for seniors across Canada. At Neighbourly, Ms. Dyer will lead the People and Culture team and will play a critical role in advancing the Company's growth through the development and continuous improvement of a Talent and Culture strategy. Ms. Dyer succeeds Roy Wieschkowski, who has decided to retire from corporate life after five successful years leading the Human Resources and Payroll teams at Neighbourly, supporting the Company's rapid growth and culture evolution. Mr. Wieschkowski's retirement marks the end of an accomplished 38 year-long career, leading Human Resources functions across various industry sectors including pharmaceuticals, retail, chemical and manufacturing. Ms. Dyer joins the Neighbourly team effective February 12, 2024.
お知らせ • Jan 19Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024Neighbourly Pharmacy Inc. announced that they will report Q3, 2024 results at 7:00 AM, US Eastern Standard Time on Feb 13, 2024
お知らせ • Oct 05PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million on October 3, 2023. As per consideration, the Persistence Capital Partners will pay CAD 20.50 in cash for each share of Neighbourly Pharmacy. The PCP GP secured fully committed debt and equity financing. Devon Park Advisors provided capital raising services to PCP. PCP currently beneficially owns or has control or direction over, directly or indirectly, 22.4 million common shares. The transaction has been unanimously approved by the Neighbourly Pharmacy board of directors. The transaction is subject to a definitive agreement, regulatory, court and/or stock exchange approvals, receiving an updated Fairness Opinion from TD and approval from shareholders of Neighbourly Pharmacy. The transaction is expected to close in the last calendar quarter of 2023 or early in the first calendar quarter of 2024. TD Securities acted as financial and provided fairness opinion to Neighbourly Pharmacy. Scotiabank and RBC Capital Markets acted as financial advisors to PCP. Stikeman Elliott LLP acted as legal advisor to PCP on the transaction. McCarthy Tétrault LLP acted as independent legal advisor to the Transaction Committee.